Molecular Pathogenesis of the Hamartoma Syndromes
错构瘤综合征的分子发病机制
基本信息
- 批准号:10221612
- 负责人:
- 金额:$ 176.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:ATP Synthesis PathwayAcetyl-CoA CarboxylaseAdultAllelesBannayan SyndromeBiguanidesCRISPR screenCandidate Disease GeneCell divisionCellsChIP-seqDefectDependenceDevelopmentDiseaseDrosophila genusEpigenetic ProcessEventFatty AcidsFrequenciesGene TargetingGenesGeneticGenetic Predisposition to DiseaseGenetic ScreeningGenetic TranscriptionGerm-Line MutationGoalsGrowthHamartomaImpairmentIn VitroIndividualKnock-outKnowledgeMalignant NeoplasmsMammalian CellMetabolicModalityModelingMolecularMultiple Hamartoma SyndromeMutationOncogenicOxidative PhosphorylationOxygenPathogenesisPathway interactionsPeutz-Jeghers SyndromePlayPrincipal InvestigatorProgram Research Project GrantsPurinesRoleSignal PathwaySignal TransductionStressSyndromeTSC1 geneTSC1/2 geneThe Cancer Genome AtlasTuberous sclerosis protein complexTumor Suppressor GenesTumor Suppressor ProteinsUnited States National Institutes of Healthascorbatecancer geneticscell killingcytotoxicefficacy evaluationgene functionin vivoinhibitor/antagonistinsightmTOR Signaling Pathwaynew therapeutic targetnovelnovel therapeutic interventionnucleotide metabolismprogramsscreeningstemtherapeutic targettranscription factortumor
项目摘要
Project Summary/Abstract
Please see each project/core for individual Project Summary/Abstract
项目总结/摘要
请参阅每个项目/核心的个别项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID J. KWIATKOWSKI其他文献
DAVID J. KWIATKOWSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID J. KWIATKOWSKI', 18)}}的其他基金
Integrative molecular dissection of acquired resistance to PD1/PD-L1 blockade in localized and metastatic urothelial carcinoma
局部和转移性尿路上皮癌对 PD1/PD-L1 阻断获得性耐药的综合分子解剖
- 批准号:
10218294 - 财政年份:2021
- 资助金额:
$ 176.14万 - 项目类别:
Integrated analyses of cancers harboring STK11 vs. TSC1/2 vs. PTEN Loss
含有 STK11、TSC1/2 和 PTEN 缺失的癌症的综合分析
- 批准号:
8567633 - 财政年份:2007
- 资助金额:
$ 176.14万 - 项目类别:
Molecular Pathogenesis of the Hamartoma Syndromes
错构瘤综合征的分子发病机制
- 批准号:
8549956 - 财政年份:2007
- 资助金额:
$ 176.14万 - 项目类别:
Molecular Pathogenesis of the Hamartoma Syndromes
错构瘤综合征的分子发病机制
- 批准号:
8719031 - 财政年份:2007
- 资助金额:
$ 176.14万 - 项目类别:
Integrated analyses of cancers harboring STK11 vs. TSC1/2 vs. PTEN Loss
含有 STK11、TSC1/2 和 PTEN 缺失的癌症的综合分析
- 批准号:
8719034 - 财政年份:2007
- 资助金额:
$ 176.14万 - 项目类别:
Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes
项目 2:识别错构瘤基因突变癌症的代谢脆弱性和靶点
- 批准号:
10715600 - 财政年份:2007
- 资助金额:
$ 176.14万 - 项目类别:
Molecular Pathogenesis of the Hamartoma Syndromes
错构瘤综合征的分子发病机制
- 批准号:
7191898 - 财政年份:2007
- 资助金额:
$ 176.14万 - 项目类别:
相似海外基金
Acetyl CoA Carboxylase in the Metabolic Control of Inflammation
乙酰辅酶A羧化酶在炎症代谢控制中的作用
- 批准号:
10660439 - 财政年份:2023
- 资助金额:
$ 176.14万 - 项目类别:
Role of Acetyl CoA carboxylase in type 2 diabetic kidney disease
乙酰辅酶A羧化酶在2型糖尿病肾病中的作用
- 批准号:
10252084 - 财政年份:2020
- 资助金额:
$ 176.14万 - 项目类别:
The role of acetyl-CoA carboxylase enzymes in fatty liver disease and cancer
乙酰辅酶A羧化酶在脂肪肝疾病和癌症中的作用
- 批准号:
nhmrc : GNT1163903 - 财政年份:2019
- 资助金额:
$ 176.14万 - 项目类别:
Project Grants
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
肝乙酰辅酶 A 羧化酶抑制对 NAFLD 和肝胰岛素抵抗的影响
- 批准号:
9763549 - 财政年份:2017
- 资助金额:
$ 176.14万 - 项目类别:
Effect of Liver-Specific Acetyl-CoA Carboxylase Inhibition on Hepatic Steatosis and Insulin Resistance
肝脏特异性乙酰辅酶A羧化酶抑制对肝脏脂肪变性和胰岛素抵抗的影响
- 批准号:
9467827 - 财政年份:2017
- 资助金额:
$ 176.14万 - 项目类别:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
肝乙酰辅酶 A 羧化酶抑制对 NAFLD 和肝胰岛素抵抗的影响
- 批准号:
9361162 - 财政年份:2017
- 资助金额:
$ 176.14万 - 项目类别:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
肝乙酰辅酶 A 羧化酶抑制对 NAFLD 和肝胰岛素抵抗的影响
- 批准号:
10217114 - 财政年份:2017
- 资助金额:
$ 176.14万 - 项目类别:
Elucidation of activation mechanism of human acetyl-CoA carboxylase
阐明人乙酰辅酶A羧化酶的激活机制
- 批准号:
22590113 - 财政年份:2010
- 资助金额:
$ 176.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Duel Functions of Acetyl-CoA Carboxylase
乙酰辅酶A羧化酶的双重功能
- 批准号:
0841143 - 财政年份:2009
- 资助金额:
$ 176.14万 - 项目类别:
Continuing Grant
Protein complex formation in the regulation and polymerization fo acetyl-coa carboxylase
乙酰辅酶A羧化酶的调节和聚合中蛋白质复合物的形成
- 批准号:
348836-2007 - 财政年份:2008
- 资助金额:
$ 176.14万 - 项目类别:
Postgraduate Scholarships - Doctoral